This content is machine translated Diabetic nephropathy Dapagliflozin and pioglitazone are not inferior as lone fighters The treatment of diabetic nephropathy (DN) has made significant progress in the past. Nevertheless, the number of diabetic patients who ultimately develop end-stage renal disease remains high. A combination of…
View Post 5 min This content is machine translated DPP4 inhibitor in adolescents with type 1 diabetes Sitagliptin add on shows renoprotective effect Children with type 1 diabetes have an increased risk of developing diabetic kidney disease (DKD). Inhibition of dipeptidyl peptidase-4 (DPP4) has positive effects on various metabolic indicators in diabetes. Egyptian…
View Post 4 min This content is machine translated Case Report Acne – successful treatment with an individual therapy concept The first case study concerns a young woman with papulopustular acne for whom teledermatology treatment proved to be effective. After around a year of treatment, the patient is now largely…
View Post 3 min This content is machine translated Diabetic kidney disease Canagliflozin approved in fast track for diabetic nephropathy Kidney protection is extremely important for diabetes sufferers. Recently, canagliflozin became the first SGLT-2 inhibitor in Switzerland to receive a marketing authorization extension to reduce the risk of progression to…
